Trial Profile
Prevention of Atrial Fibrillation in Patients Undergoing Thoracic Surgery for Lung Cancer.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Metoprolol (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- Acronyms PRESAGE
- 04 Sep 2012 Planned end date changed from 1 Mar 2015 to 1 Dec 2015 as reported by ClinicalTrials.gov.
- 02 Aug 2011 Planned End Date changed from 1 Mar 2013 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 01 Feb 2011 New trial record